{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:20Z","timestamp":1789538780331,"version":"build-2803163510"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"K\u00f6lnFortune"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We analyzed the role of neurosurgery combined with postoperative treatment according to current guidelines in a real-world cohort of patients with brain metastasis (BM) over an 11-year period to (re-)evaluate predictors of local intracranial recurrence (LR) and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted the SUBARoMA study (Surgery for brain metastases: a retrospective multicenter analysis), including patients undergoing surgery as initial treatment for their BM. Significant factors impacting LR and OS were analyzed by univariate (Kaplan-Meier) and multivariate (Cox regression) methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 2,751 patients. Resection significantly improved patients\u2019 postoperative Karnofsky Performance Score (KPS, P\u2009&amp;lt;\u2009.001). Gross-total resection (rate 73%) increased by fluorescence guidance but exerted no effect on morbidity (rate 20.4%) (P\u2009&amp;lt;\u2009.001, respectively). The risk of LR was 23.5% at 1 year and 40.4% at 4 years. Postoperative systemic- (P\u2009=\u2009.021) and radiotherapy (P\u2009&amp;lt;\u2009.001) had an independent impact on LR. Mean\/median OS was 15.0\/7.5 months. The strongest independent predictors of OS were age, number of BM, active extracranial tumor, as well as improvement of postoperative KPS, radiation-, and systemic therapy including targeted and\/or immunotherapy (P\u2009&amp;lt;\u2009.001, respectively). Over the 11-year period, application of whole-brain radiotherapy decreased in favor of focal radiation, and administration of systemic treatment, particularly targeted and\/or immunotherapies, increased. By combining surgery, postoperative radiation, and systemic therapy, 5-year survival rates of &amp;gt;30% were achieved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The SUBARoMA study confirms the crucial role of neurosurgery for patients with BM by improving their KPS to enable guideline-conforming postoperative treatment and underscores meticulous patient selection for surgical management of BM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/nop\/npaf128","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:58:15Z","timestamp":1765630695000},"page":"877-889","source":"Crossref","is-referenced-by-count":4,"title":["The role of neurosurgery for brain metastases between 2012 and 2022: Results of the multicenter\n                    <i>SUBAROMA<\/i>\n                    study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9744-8204","authenticated-orcid":false,"given":"Stephanie T","family":"J\u00fcnger","sequence":"first","affiliation":[{"name":"Department of General Neurosurgery, Faculty of Medicine and University Hospital Cologne, Center for Neurosurgery, University of Cologne , Cologne"},{"name":"Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology, University of Cologne , Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanah Hadice","family":"Karadachi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Spine Surgery, University \u00adHospital Essen , Essen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-1821","authenticated-orcid":false,"given":"Ulrich","family":"Sure","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Spine Surgery, University \u00adHospital Essen , Essen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Ahmadipour","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Spine Surgery, University \u00adHospital Essen , Essen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levin","family":"H\u00e4ni","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Inselspital, Bern University Hospital and University of Bern , Bern"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3586-2079","authenticated-orcid":false,"given":"Danial","family":"Nasiri","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Inselspital, Bern University Hospital and University of Bern , Bern"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Araceli","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Regensburg University Medical Center , Regensburg"},{"name":"\u00adWilhelm Sander-NeuroOncology Unit, Regensburg University Medical Center , Regensburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Proescholdt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Regensburg University Medical Center , Regensburg"},{"name":"\u00adWilhelm Sander-NeuroOncology Unit, Regensburg University Medical Center , Regensburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Ole","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Regensburg University Medical Center , Regensburg"},{"name":"\u00adWilhelm Sander-NeuroOncology Unit, Regensburg University Medical Center , Regensburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital W\u00fcrzburg , W\u00fcrzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Nickl","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital W\u00fcrzburg , W\u00fcrzburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Scheichel","sequence":"additional","affiliation":[{"name":"Karl Landsteiner University of Health Sciences , Krems"},{"name":"Division of Neurosurgery, University Hospital St. Poelten , St. P\u00f6lten"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Marhold","sequence":"additional","affiliation":[{"name":"Karl Landsteiner University of Health Sciences , Krems"},{"name":"Division of Neurosurgery, University Hospital St. Poelten , St. P\u00f6lten"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J","family":"Grau","sequence":"additional","affiliation":[{"name":"Department of General Neurosurgery, Faculty of Medicine and University Hospital Cologne, Center for Neurosurgery, University of Cologne , Cologne"},{"name":"Klinikum Fulda, Academic Hospital of \u00adMarburg University , Fulda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A","family":"Hamisch","sequence":"additional","affiliation":[{"name":"Department of General Neurosurgery, Faculty of Medicine and University Hospital Cologne, Center for Neurosurgery, University of Cologne , Cologne"},{"name":"Klinikum Fulda, Academic Hospital of \u00adMarburg University , Fulda"},{"name":"Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, Center for Neurosurgery, University of Cologne , Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz L","family":"Ricklefs","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Center Hamburg Eppendorf , Eppendorf"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Zghaibeh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical Center Hamburg Eppendorf , Eppendorf"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Nogova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology, University of Cologne , Cologne"},{"name":"Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne , Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kocher","sequence":"additional","affiliation":[{"name":"Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, Center for Neurosurgery, University of Cologne , Cologne"},{"name":"Institute for Neuroscience and Medicine, Forschungszentrum J\u00fclich , J\u00fclich"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland H","family":"Goldbrunner","sequence":"additional","affiliation":[{"name":"Department of General Neurosurgery, Faculty of Medicine and University Hospital Cologne, Center for Neurosurgery, University of Cologne , Cologne"},{"name":"Faculty of Medicine and University Hospital Cologne, Center for Integrated Oncology, University of Cologne , Cologne"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2026091601520332000_npaf128-B1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"2026091601520332000_npaf128-B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0360-3016(80)90195-9","article-title":"The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group","volume":"6","author":"Borgelt","year":"1980","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"2026091601520332000_npaf128-B3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0360-3016(81)90005-5","article-title":"The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group","volume":"7","author":"Kurtz","year":"1981","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"2026091601520332000_npaf128-B4","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/archneur.1978.00500350058012","article-title":"Treatment for patients with cerebral metastases","volume":"35","author":"Markesbery","year":"1978","journal-title":"Arch Neurol"},{"key":"2026091601520332000_npaf128-B5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3171\/jns.1996.84.5.0748","article-title":"Surgery versus radiosurgery in the treatment of brain metastasis","volume":"84","author":"Bindal","year":"1996","journal-title":"J Neurosurg"},{"key":"2026091601520332000_npaf128-B6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00701-013-1619-y","article-title":"The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study","volume":"155","author":"Lee","year":"2013","journal-title":"Acta Neurochir (Wien)"},{"key":"2026091601520332000_npaf128-B7","first-page":"1021","article-title":"Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques","volume":"56","author":"Paek","year":"2005","journal-title":"Neurosurgery"},{"key":"2026091601520332000_npaf128-B8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ana.410330605","article-title":"Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery","volume":"33","author":"Vecht","year":"1993","journal-title":"Ann Neurol"},{"key":"2026091601520332000_npaf128-B9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3171\/jns.1995.83.4.0605","article-title":"Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991","volume":"83","author":"Wro\u0144ski","year":"1995","journal-title":"J Neurosurg"},{"key":"2026091601520332000_npaf128-B10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s10637-018-0668-8","article-title":"E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases","volume":"37","author":"Babiker","year":"2019","journal-title":"Invest New Drugs"},{"key":"2026091601520332000_npaf128-B11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","article-title":"Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial","volume":"17","author":"Goldberg","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026091601520332000_npaf128-B12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"2026091601520332000_npaf128-B13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N Engl J Med"},{"key":"2026091601520332000_npaf128-B14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/CMR.0b013e32834d3d88","article-title":"Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial","volume":"21","author":"Weber","year":"2011","journal-title":"Melanoma Res"},{"key":"2026091601520332000_npaf128-B15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jamaoncol.2018.4610","article-title":"Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection: a secondary analysis of a randomized clinical trial","volume":"5","author":"Churilla","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026091601520332000_npaf128-B16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026091601520332000_npaf128-B17","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"2026091601520332000_npaf128-B18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"2026091601520332000_npaf128-B19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-Centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026091601520332000_npaf128-B20","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"2026091601520332000_npaf128-B21","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other Central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro-oncology"},{"key":"2026091601520332000_npaf128-B22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s00066-018-1368-1","article-title":"Postoperative local fractionated radiotherapy for resected single brain metastases","volume":"194","author":"Ayas","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"2026091601520332000_npaf128-B23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant Whole-Brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","author":"Kocher","year":"2011","journal-title":"Journal of Clinical Oncology"},{"key":"2026091601520332000_npaf128-B24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/neuros\/nyy540","article-title":"Congress of neurological surgeons systematic review and Evidence-Based guidelines for the treatment of adults with metastatic brain tumors: executive summary","volume":"84","author":"Olson","year":"2019","journal-title":"Neurosurgery"},{"key":"2026091601520332000_npaf128-B25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026091601520332000_npaf128-B26","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1002\/cam4.3402","article-title":"Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment","volume":"9","author":"Sch\u00f6del","year":"2020","journal-title":"Cancer Med"},{"key":"2026091601520332000_npaf128-B27","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.3390\/cancers12123618","article-title":"Timing of development of symptomatic brain metastases from non-small cell lung cancer: impact on symptoms, treatment, and survival in the era of molecular treatments","volume":"12","author":"J\u00fcnger","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026091601520332000_npaf128-B28","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/cancers13061435","article-title":"The debatable benefit of Gross-Total resection of brain metastases in a comprehensive treatment setting","volume":"13","author":"J\u00fcnger","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026091601520332000_npaf128-B29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.wneu.2017.10.145","article-title":"Clinical features of precocious, synchronous, and metachronous brain metastases and the role of tumor resection","volume":"113","author":"Shibahara","year":"2018","journal-title":"World Neurosurg."},{"key":"2026091601520332000_npaf128-B30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3171\/jns.2000.93.6.0927","article-title":"Survival of patients with synchronous brain metastases: an epidemiological study in southeastern Michigan","volume":"93","author":"Thomas","year":"2000","journal-title":"J Neurosurg"},{"key":"2026091601520332000_npaf128-B31","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3171\/2014.9.JNS13939","article-title":"Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis","volume":"122","author":"Patel","year":"2015","journal-title":"J Neurosurg"},{"key":"2026091601520332000_npaf128-B32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijrobp.2006.03.050","article-title":"A pathology-based substrate for target definition in radiosurgery of brain metastases","volume":"66","author":"Baumert","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026091601520332000_npaf128-B33","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/neuonc\/not112","article-title":"Invasion patterns in brain metastases of solid cancers","volume":"15","author":"Berghoff","year":"2013","journal-title":"Neuro Oncol"},{"key":"2026091601520332000_npaf128-B34","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ijrobp.2010.07.034","article-title":"Metastasis infiltration: an investigation of the postoperative brain-tumor interface","volume":"81","author":"Raore","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026091601520332000_npaf128-B35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026091601520332000_npaf128-B36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11060-025-05075-0","article-title":"Reconsideration of the resection strategy of eloquent brain metastasis in the era of postoperative stereotactic radiotherapy: a comparative analysis with non-eloquent metastasis","volume":"174","author":"H\u00e4ni","year":"2025","journal-title":"J Neurooncol"},{"key":"2026091601520332000_npaf128-B37","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2023.5.FOCUS23197","article-title":"Brain metastasis resection: the impact of fluorescence guidance (MetResect study)","volume":"55","author":"Schebesch","year":"2023","journal-title":"Neurosurg Focus"},{"key":"2026091601520332000_npaf128-B38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00701-022-05417-1","article-title":"Mind the gap\u2014the use of sodium fluoresceine for resection of brain metastases to improve the resection rate","volume":"165","author":"Kerschbaumer","year":"2023","journal-title":"Acta Neurochir"},{"key":"2026091601520332000_npaf128-B39","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1227\/neu.0000000000002542","article-title":"Causes of death in patients with brain metastases","volume":"93","author":"Schnurman","year":"2023","journal-title":"Neurosurgery"},{"key":"2026091601520332000_npaf128-B40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0360-3016(98)00198-9","article-title":"Prognostic factors derived from recursive partition analysis (RPA) of radiation therapy oncology group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases","volume":"42","author":"Agboola","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026091601520332000_npaf128-B41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijrobp.2014.07.002","article-title":"Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA)","volume":"90","author":"Sperduto","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026091601520332000_npaf128-B42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"}],"container-title":["Neuro-Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nop\/advance-article-pdf\/doi\/10.1093\/nop\/npaf128\/65924946\/npaf128.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/13\/5\/877\/65924946\/npaf128.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nop\/article-pdf\/13\/5\/877\/65924946\/npaf128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:52:10Z","timestamp":1789537930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nop\/article\/13\/5\/877\/8381543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,12,16]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nop\/npaf128","relation":{},"ISSN":["2054-2577","2054-2585"],"issn-type":[{"value":"2054-2577","type":"print"},{"value":"2054-2585","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2025,12,16]]}}}